(NewsNation) — Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past few years. Part of that controversy deals with the ...

Gastrointestinal issues are common in patients taking GLP-1 weight loss drugs like Ozempic and Wegovy, but there are some lesser known side effects that range from bothersome to bizarre.

Weight loss drugs are controversial, in part, due to the side effects they cause. Part of the controversy surrounding weight loss drugs like Ozempic and Mounjaro involve their side effects. Skip ...

Weight loss drugs have long occupied a complicated space in medicine—offering hope for those struggling with obesity while simultaneously sparking controversy due to side effects, misuse, and ...

Unlike semaglutide, BRP appeared to activate separate metabolic and neuronal pathways, suggesting it could offer weight-loss benefits without some of the gastrointestinal side effects commonly ...

Both tirzepatide and semaglutide have helped people lose weight in earlier studies, but this is the first time they've been compared side by side. Of the 751 people in the study, half took ...

Weight loss medications are controversial due to some of the side effects caused by the most popular drugs. Part of the controversy surrounding weight loss drugs like Ozempic and Mounjaro involve ...

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past few years. Part of that controversy deals with the side effects caused ...

The combination of fenfluramine and phentermine—fen-phen—was a popular treatment by the 1990s. It showed promising weight loss results but soon led to reports of cardiac valvulopathy and ...

1999–2009: Lean Years for Innovation. Approved in 1999, orlistat was one of the few remaining FDA-approved weight loss medications. It inhibits pancreatic lipase to reduce fat absorption.